John Hart to Barrett Esophagus
This is a "connection" page, showing publications John Hart has written about Barrett Esophagus.
Connection Strength
2.248
-
Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up. Mod Pathol. 2015 May; 28(5):654-61.
Score: 0.481
-
Effects of dropping the requirement for goblet cells from the diagnosis of Barrett's esophagus. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1232-6.
Score: 0.405
-
Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologists. Virchows Arch. 2021 Jun; 478(6):1061-1069.
Score: 0.184
-
The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus-associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society. Am J Surg Pathol. 2017 May; 41(5):e8-e21.
Score: 0.143
-
Post-ablation surveillance in Barrett's esophagus: A review of the literature. World J Gastroenterol. 2016 May 07; 22(17):4297-306.
Score: 0.133
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.115
-
Development of subsquamous cancer after hybrid endoscopic therapy for intramucosal Barrett's cancer. Endoscopy. 2012; 44 Suppl 2 UCTN:E390-1.
Score: 0.105
-
Evaluation of microvascular density in Barrett's associated neoplasia. Mod Pathol. 2013 Jan; 26(1):125-30.
Score: 0.103
-
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46.
Score: 0.101
-
Confocal laser endomicroscopy: potential in the management of Barrett's esophagus. Dis Esophagus. 2010 Jul; 23(5):E21-31.
Score: 0.089
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.084
-
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009 Sep; 70(3):417-21.
Score: 0.083
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.074
-
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005 Apr 15; 65(8):3146-54.
Score: 0.062
-
Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002 Jan; 97(1):27-31.
Score: 0.049
-
Prostate-specific membrane antigen expression in regeneration and repair. Mod Pathol. 2008 Dec; 21(12):1421-7.
Score: 0.020
-
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007 Dec; 39(12):1086-91.
Score: 0.018